Strategic Partnership MED Institute has recently allied with 3Aware to enhance real-world evidence generation for medical devices, presenting a sales opportunity to offer integrated RWE and regulatory/compliance services to manufacturers seeking robust post-market insights.

Leadership Transition A recent leadership change with the retirement of long-time President Neal Fearnot signals potential outreach for continuity planning services, potential engagements around governance, strategic advisory, and leadership-level partnerships.

MRI Safety Expansion Expansion of MRI safety evaluation capabilities suggests an opportunity to offer advanced testing, labeling support, and alternative methods for MR Conditional labeling to medical device companies developing or updating implant and imaging devices.

Regulatory & Trials Focus With over four decades of experience in regulatory submissions, clinical trials, and risk/quality processes, MED Institute presents a fit for end-to-end support, including premarket validation, DMRL/DSU readiness, and post-market surveillance programs.

Mid-Market Footprint Revenue scale and employee count position MED Institute as a mid-market CRO/consulting partner, making it a compelling target for mid-sized device firms seeking established, cost-effective regulatory and testing services aligned with market entry timelines.